Status:
COMPLETED
Comparing PPG-based Blood Pressure Measurement to the Gold Standard Manometer
Lead Sponsor:
Biobeat Technologies Ltd.
Conditions:
Hypertension
Blood Pressure Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Continuous blood pressure (BP) measurement is in use today with an ambulatory, sphygmomanometer-based, device. This device, also called BP Holter, gives essential data for the clinician, allowing bett...
Detailed Description
HTN is a major risk factor for cerebrovascular morbidity and mortality, yet its identification can be delayed due to lack of overt symptoms, relying on BP measurements for diagnosis. Several BP monito...
Eligibility Criteria
Inclusion
- Either healthy or chronically ill who are treated accordingly and with no need of any medical intervention during the study.
Exclusion
- A volunteer's refusal to enter the study.
- Patients who are currently in hospitalization or in medical assessment.
- Pregnant women and children under 18.
- Volunteers with powerless jurisdiction.
- Workers of the Hadassah Medical Center
Key Trial Info
Start Date :
April 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2020
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03810586
Start Date
April 15 2019
End Date
June 25 2020
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hadassah Ein Kerem Medical Center
Jerusalem, Israel